Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of July 23, 2025 • 8:01 AM ET

Date/Time Source News Release
07/22/2025 08:42 AM EDT PR Newswire Award-Winning Broadway, Television & Film Star Aaron Lazar Featuring NeuroSense CEO Alon Ben-Noon in a Special Live Podcast on ALS Science, PrimeC's Commercialization Strategies, and Community
05/07/2025 08:45 AM EDT PR Newswire NeuroSense Therapeutics Announces Successful Completion of Commercial Manufacturing Scale-Up for PrimeC in Preparation for Potential Canadian Market Launch
04/24/2025 09:09 AM EDT PR Newswire NeuroSense Therapeutics Releases Letter to Shareholders Outlining Clinical Progress, Regulatory Strategy, and Partnership Update
04/09/2025 08:30 AM EDT PR Newswire NeuroSense Therapeutics Announces Transformative Phase 2b MicroRNA Data, Highlighting PrimeC's Promise as a Disease-Modifying ALS Treatment
04/07/2025 05:14 PM EDT PR Newswire NeuroSense Therapeutics Reports Year End 2024 Financial Results and Provides Business Updates
04/04/2025 09:10 AM EDT PR Newswire NeuroSense Therapeutics to Present New Data from PrimeC's Phase 2b Trial in ALS at the Annual American Academy of Neurology Meeting
03/20/2025 10:30 AM EDT Business Wire Market Alert: NeuroSense Therapeutics Advances Toward Early Canadian Commercialization of ALS Drug
03/17/2025 08:30 AM EDT Business Wire PESG Releases Report on NeuroSense Therapeutics: Groundbreaking ALS Therapy Signals Massive Potential Opportunity in Billion Dollar Treatment Landscape
01/06/2025 09:00 AM EST PR Newswire NeuroSense Regains Compliance with Nasdaq's Minimum Equity Requirement
12/23/2024 09:00 AM EST PR Newswire NeuroSense Therapeutics Enters Binding Term Sheet to Advance PrimeC for ALS
Page

Additional News

As of July 23, 2025 • 8:01 AM ET

Date/Time Source News Release
06/30/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, June 30th, 2025
06/30/2025 05:31 AM EDT US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
06/23/2025 06:46 PM EDT KlickAnalytics NRSN - Historical Price Movements Surrounding Earnings
06/23/2025 06:41 PM EDT KlickAnalytics NRSN - Historical Earnings Price Analysis
06/23/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, June 23rd, 2025
06/23/2025 05:31 AM EDT US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
05/21/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Earnings Results Guides NextGen Tech & AI Index Lower
04/08/2025 03:45 AM EDT SeekingAlpha NeuroSense Therapeutics GAAP EPS of -$0.54
04/04/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Friday, April 4th, 2025
04/04/2025 05:30 AM EDT US Earnings Reports Expected earnings - NeuroSense Therapeutics Ltd.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.